GLP-1s May Quiet ‘Food Noise’
GLP-1 patients have been surprised to discover they no longer think about food as often—their “food noise” has decreased or disappeared.
GLP-1 patients have been surprised to discover they no longer think about food as often—their “food noise” has decreased or disappeared.
A two-year drug trial examining whether GLP-1s could slow progression of Alzheimer’s disease has shown disappointing results. The drug company Novo Nordisk’s EVOKE/EVOKE+ Phase 3 trial studied whether the drug semaglutide is safe and effective at treating mild cognitive impairment (MCI) due to Alzheimer’s disease. Semaglutide is a GLP-1 receptor agonist better known under its […]